Nanoemulsion Market

Nanoemulsion Market Size:

The global nanoemulsion market size reached US$ 11.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 22.8 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032. The market is flourished by the increasing consumer awareness about nutraceuticals, rising demand for advanced drug delivery systems, ongoing research and development (R&D) activities in nanotechnology, and expanding product applications in the food and beverage industry.

Nanoemulsion Market Analysis:

• Major Market Drivers: The major drivers for market growth include the expanding product applications in the food and beverage industry for enhancing the solubility and stability of ingredients, the rising need for improved drug delivery systems due to their advanced bioavailability and targeted delivery capabilities, ongoing improvements in nanotechnology, and growing consumer awareness of the health benefits of functional foods and nutraceuticals.
• Key Market Trends: Some of the key trends in the market involve the growing product employment in cosmetics and personal care industry due to their properties like improved skin absorption and stability. In addition, technological advancements in production techniques, such as high-pressure homogenization and ultrasonic emulsification, is favoring the market growth. Moreover, the increasing employment of nanoemulsions in the food and beverage (F&B) industry to enhance the delivery of hydrophobic bioactive compounds is notable.
• Geographical Trends: North America dominates the nanoemulsion market due to its robust pharmaceutical and biotechnology sectors, favorable investments in R&D, and widespread adoption of advanced technologies. The region's well-established healthcare infrastructure and the presence of key market players further bolster market growth. Additionally, increasing consumer demand for functional foods, beverages, and personal care products with enhanced efficacy contributes to the region’s market dominance. Supportive regulatory frameworks and government initiatives promoting nanotechnology research also play a crucial role.
• Competitive Landscape: Some of the major market players in the Nanoemulsion industry include Ascendia Pharmaceuticals, B. Braun Melsungen AG, BlueWillow Biologics Inc., Covaris Inc., Fresenius Kabi AG, IDEX Corporation, Kaken Pharmaceutical Co. Ltd., Latitude Pharmaceuticals Inc., Owen Biosciences Inc., Santen Pharmaceutical Co. Ltd, and Taiwan Liposome Co. Ltd., among many others.
• Challenges and Opportunities: Opportunities in the market include the potential for innovative applications in drug delivery, food and beverage enhancement, and personal care products. Emerging markets and advancements in nanotechnology offer significant growth prospects. However, challenges, such as high production costs, regulatory hurdles, and potential toxicity issues associated with nano-sized particles, can impede market growth.

Nanoemulsion Market Trends:

Increasing Need for Enhanced Drug Delivery Systems

Nanoemulsions enhance the bioavailability and targeted delivery of therapeutic agents, making them effective for poorly soluble drugs. Their small droplet size ensures better absorption and distribution, driving pharmaceutical companies to invest in nanoemulsion-based formulations. The rising prevalence of chronic diseases and the preference for precision drug delivery systems increase global demand. Moreover, nanoemulsions are used for targeted delivery of anticancer drugs and other therapeutic agents, improving efficacy and minimizing side effects. The aging population's susceptibility to health disorders also boosts demand, especially for treating reticuloendothelial system infections and liver enzyme replacement therapy. According to WHO, chronic diseases are responsible for 74% of global deaths, while cancer accounted for nearly 10 million deaths in 2020, further underscoring the need for advanced drug delivery systems like nanoemulsions, particularly in low- and middle-income countries. Additionally, biopharmaceutical companies are leveraging nanoemulsions in vaccine production, exemplified by BlueWillow Biologics' patented NanoVax intranasal anthrax vaccine.

Growing Applications in Food and Beverage Industry

The food and beverage industry utilizes nanoemulsions to enhance the solubility, stability, and bioavailability of hydrophobic ingredients such as vitamins, flavors, and antioxidants. This improves the nutritional value and sensory properties of products, catering to the rising consumer demand for functional foods and beverages. The versatility of nanoemulsions in creating stable, clear, and homogeneous products further boosts their adoption in products like energy drinks, health drinks, dairy products, bakery goods, and salads and dressings. In 2023, the U.S. sales of functional foods and beverages reached $92.1 billion, with projections by Nutrition Business Journal indicating a growth to $106.9 billion by 2026 at a CAGR of 5%. The interest in these products is higher among younger demographics, with two-thirds of millennials and households with children, half of Gen Z and Gen X, and one-third of baby boomers purchasing functional foods. Nearly half (47%) of U.S. adults are proactive health consumers, according to NIQ, and 48% plan to eat healthier in 2024, as reported by FMI. Globally, over half of consumers select foods to enhance performance, mood, and sleep. Currently, over half of the U.S. food companies are reformulating products to add health benefits, with 22% planning to do so within the next two years, focusing on reducing sugars and sodium and adding beneficial ingredients.

Rising Consumer Awareness of Nutraceuticals

Growing awareness of the health benefits associated with nutraceuticals and functional foods drives the demand for nanoemulsion-based products. Nanoemulsions offer superior delivery of bioactive compounds, ensuring better absorption and efficacy. This trend is supported by increasing health consciousness among consumers and the desire for products that provide specific health benefits, leading to greater market expansion. According to a research report published on PMC in June 2023, the nutraceutical market in India is rapidly evolving and is projected to reach USD 18 billion by the end of 2025, up from USD 4 billion at the end of 2020. This represents more than a fourfold increase over five years. The significant growth is partly driven by increased foreign investment, spurred by the introduction of 100% Foreign Direct Investment (FDI) in the nutraceutical and food supplement manufacturing sector. Consequently, FDI in this sector surged from USD 131.4 million in 2012 to USD 584.7 million in 2019. With this remarkable growth trajectory, India is on track to become a global leader in the nutraceutical industry.

Nanoemulsion Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, route of administration, and application.

Breakup by Type:

• Small-molecule Surfactant
• Protein-stabilized Emulsions
• Polysaccharide
   

Small-molecule surfactant accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes small-molecule surfactant, protein-stabilized emulsions, and polysaccharide. According to the report, small-molecule surfactant represented the largest segment.

Small-molecule surfactants lead the nanoemulsion market size due to their ability to reduce interfacial tension effectively, resulting in stable and uniform nano-sized droplets. Their amphiphilic nature allows them to enhance the solubility and bioavailability of hydrophobic compounds, making them ideal for applications in pharmaceuticals, cosmetics, and food industries. Moreover, they are cost-effective and versatile, enabling efficient production processes and broad compatibility with various formulation components, thus driving their dominance in the market.

Breakup by Route of Administration:

• Oral
• Parenteral
• Others
   

A detailed breakup and analysis of the market based on the route of administration have also been provided in the report. This includes oral, parenteral, and others.

Oral nanoemulsions improve the bioavailability and absorption of poorly soluble drugs, mask unpleasant tastes, and protect sensitive compounds, making them highly demanded in nutraceuticals and functional foods.

Parenteral nanoemulsions enable targeted, controlled drug delivery with superior tissue penetration for intravenous, intramuscular, and subcutaneous administration, enhancing treatment efficacy for chronic diseases and vaccines. Topical and ocular nanoemulsions improve drug penetration and efficacy in dermatology, cosmetics, and eye treatments, driven by the need for advanced drug delivery systems in various medical fields.

Oral and parenteral nanoemulsions are widely used, while other methods, such as ocular delivery, are also significant. Companies in the market collaborate on novel product development. For instance, in June 2020, Ascendia Pharmaceuticals utilized its EmulSol technology to create ASD-004, a clear emulsion cyclosporin eyedrop for dry eyes. Such initiatives are expected to drive market growth in the coming years.

Breakup by Application:

• Anesthetics
• Antibiotics
• Nonsteroidal Anti-inflammatory Drugs
• Immunosuppressants
• Steroids
• Others
   

Immunosuppressants represents the leading market segment 

The report has provided a detailed breakup and analysis of the market based on the application. This includes anesthetics, antibiotics, nonsteroidal anti-inflammatory drugs, immunosuppressants, steroids, and others. According to the report, immunosuppressants represented the largest segment.

Immunosuppressants lead the nanoemulsion market due to their critical role in enhancing drug delivery systems for these potent medications. Nanoemulsions improve the bioavailability and targeted delivery of immunosuppressants, ensuring more effective management of conditions such as organ transplants and autoimmune diseases. The small droplet size of nanoemulsions facilitates better absorption and distribution of the drugs within the body, reducing side effects and improving therapeutic outcomes. This has led to significant research and development investments, driving market growth in this segment.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

North America leads the market, accounting for the largest nanoemulsion market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for nanoemulsion.

North America dominates the nanoemulsion market share due to its strong pharmaceutical and biotechnology sectors, significant R&D investments, and early adoption of advanced technologies. The region's established healthcare infrastructure and the presence of major market players further support market growth. Additionally, increasing consumer demand for functional foods, beverages, and personal care products with enhanced efficacy contributes to the market's dominance. Supportive regulatory frameworks and government initiatives promoting nanotechnology research also play crucial roles in bolstering North America's leadership in this sector.

In February 2020, Pressure BioSciences Inc., a Massachusetts-based company, announced the launch of its Ultra Shear Technology (UST) Demonstration Laboratory. Located at the company's South Easton facility in Massachusetts, the UST Demo Lab is designed to process CBD oil into high-quality, water-soluble nanoemulsions. This facility aims to explore methods for making hemp-derived cannabinoid oil effectively soluble in water, thereby optimizing its absorption and bioavailability when consumed or applied.

Competitive Landscape:

• The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the nanoemulsion industry include Ascendia Pharmaceuticals, B. Braun Melsungen AG, BlueWillow Biologics Inc., Covaris Inc., Fresenius Kabi AG, IDEX Corporation, Kaken Pharmaceutical Co. Ltd., Latitude Pharmaceuticals Inc., Owen Biosciences Inc., Santen Pharmaceutical Co. Ltd and Taiwan Liposome Co. Ltd.
  
  (Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
   
• The competitive landscape of the nanoemulsion market is characterized by the presence of several key players actively involved in research, innovation, and product development. Major companies are focusing on leveraging advanced technologies to enhance the bioavailability and stability of nanoemulsion-based products. Collaborations, partnerships, and strategic alliances are common, as companies aim to expand their product portfolios and market reach. The market is also witnessing significant investment in R&D to explore new applications in pharmaceuticals, cosmetics, and the food and beverage industry, driving further competition and innovation​.
• In July 2021, Seppic introduced Simaline L80, a new liquid emulsifier designed for topical drugs and medical devices. Simaline L80 is made from raw materials compliant with the European Pharmacopoeia. When combined with the Sepineo™ polymer range, it offers a novel solution for formulating dosage forms that enhance solvent/penetration compatibility, provide a unique texture, and simplify manufacturing.

Nanoemulsion Market News:

• In June 2023, Ascendia Pharmaceuticals developed a novel nanoemulsion IV formulation for clopidogrel using its patented EmulSol® nanotechnology. This formulation, created in partnership with AcuteBio, LLC, has received Investigational New Drug (IND) approval from the FDA.
• In May 2024, B. Braun Medical Inc., a leader in smart infusion therapy and pain management, has announced a collaboration agreement with Orlando Health, a nationally recognized healthcare provider known for its award-winning hospitals. This partnership aims to jointly develop innovative solutions to enhance access to care for patients and clinicians. The collaboration focuses on addressing disruptions in the pharmacy and infusion therapy landscape by gathering early clinician feedback to identify needs and create targeted solutions.

Nanoemulsion Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the nanoemulsion market from 2018-2032.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the global nanoemulsion market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the nanoemulsion industry and its attractiveness.
• The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.